Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women From the European Prospective Investigation Into Cancer and Nutrition.
Journal
American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653
Informations de publication
Date de publication:
01 02 2019
01 02 2019
Historique:
received:
05
09
2018
accepted:
16
11
2018
pubmed:
28
11
2018
medline:
19
11
2019
entrez:
28
11
2018
Statut:
ppublish
Résumé
The role of hormonal factors in the etiology of lymphoid neoplasms remains unclear. Previous studies have yielded conflicting results, have lacked sufficient statistical power to assess many lymphoma subtypes, or have lacked detailed information on relevant exposures. Within the European Prospective Investigation Into Cancer and Nutrition cohort, we analyzed comprehensive data on reproductive factors and exogenous hormone use collected at baseline (1992-2000) among 343,458 women, including data on 1,427 incident cases of B-cell non-Hodgkin lymphoma (NHL) and its major subtypes identified after a mean follow-up period of 14 years (through 2015). We estimated hazard ratios and 95% confidence intervals using multivariable proportional hazards modeling. Overall, we observed no statistically significant associations between parity, age at first birth, breastfeeding, oral contraceptive use, or ever use of postmenopausal hormone therapy and risk of B-cell NHL or its subtypes. Women who had undergone surgical menopause had a 51% higher risk of B-cell NHL (based on 67 cases) than women with natural menopause (hazard ratio = 1.51, 95% confidence interval: 1.17, 1.94). Given that this result may have been due to chance, our results provide little support for the hypothesis that sex hormones play a role in lymphomagenesis.
Identifiants
pubmed: 30481275
pii: 5210910
doi: 10.1093/aje/kwy259
pmc: PMC6357796
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
274-281Subventions
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C8221/A19170
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C570/A16491
Pays : United Kingdom
Références
J Clin Epidemiol. 2008 Sep;61(9):945-50
pubmed: 18468857
Oncotarget. 2016 Apr 12;7(15):20718-27
pubmed: 26943574
Leukemia. 2011 Jul;25(7):1103-10
pubmed: 21502954
Leuk Lymphoma. 2017 Mar;58(3):528-539
pubmed: 27557932
Int J Cancer. 1993 Jan 21;53(2):215-9
pubmed: 8425757
Ann Oncol. 2012 Sep;23(9):2362-74
pubmed: 22786757
PLoS One. 2009 Dec 02;4(12):e8135
pubmed: 19956586
Int J Cancer. 2011 Aug 15;129(4):974-82
pubmed: 20957632
J Clin Oncol. 2001 Mar 1;19(5):1381-7
pubmed: 11230482
Cancer Causes Control. 2004 May;15(4):419-28
pubmed: 15141141
Am J Epidemiol. 2008 Aug 1;168(3):278-88
pubmed: 18550561
J Pathol. 2006 Feb;208(3):408-14
pubmed: 16294372
J Natl Cancer Inst. 1997 Feb 19;89(4):314-8
pubmed: 9048836
Leuk Lymphoma. 2012 Jan;53(1):139-44
pubmed: 21767241
J Clin Endocrinol Metab. 2007 Aug;92(8):3040-3
pubmed: 17519304
Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):217-21
pubmed: 26464426
Ann Oncol. 2013 Feb;24(2):433-41
pubmed: 22967995
Cancer Causes Control. 2010 Dec;21(12):2079-83
pubmed: 20697798
Proc Natl Acad Sci U S A. 2003 May 27;100(11):6694-9
pubmed: 12740446
Crit Rev Oncol Hematol. 2014 Dec;92(3):181-93
pubmed: 25132165
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):130-44
pubmed: 25174034
Am J Epidemiol. 2004 Oct 15;160(8):766-73
pubmed: 15466499
Swiss Med Wkly. 2010 Apr 3;140(13-14):187-201
pubmed: 20175004
Cancer Causes Control. 2013 Jul;24(7):1279-89
pubmed: 23568533
Ann N Y Acad Sci. 2010 Apr;1193:36-42
pubmed: 20398006
Stat Med. 2016 Feb 28;35(5):782-800
pubmed: 26619806
Ann Intern Med. 2002 Aug 20;137(4):273-84
pubmed: 12186518
Neoplasma. 1990;37(2):185-90
pubmed: 2342631
Cancer Res. 1992 Oct 1;52(19 Suppl):5510s-5515s
pubmed: 1394165
Cancer Causes Control. 2002 Mar;13(2):131-6
pubmed: 11936819
Exp Hematol. 2017 May;49:34-38.e2
pubmed: 28115200
Int J Cancer. 1997 Jan 17;70(2):155-8
pubmed: 9009153
Leuk Res. 1997 Sep;21(9):885-8
pubmed: 9393604
Am J Epidemiol. 2018 Aug 1;187(8):1630-1641
pubmed: 29394309
Int J Cancer. 2016 Feb 1;138(3):604-11
pubmed: 26365326
Leuk Lymphoma. 2013 Apr;54(4):720-5
pubmed: 22916741
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Cancer Causes Control. 2003 Sep;14(7):639-44
pubmed: 14575361
J Chronic Dis. 1980;33(10):595-605
pubmed: 7410520
Cancer Causes Control. 2012 Jan;23(1):195-206
pubmed: 22116538
Hum Reprod Update. 2005 Jul-Aug;11(4):411-23
pubmed: 15817524
Br J Haematol. 2010 Mar;148(5):739-53
pubmed: 19958356
Br J Cancer. 2006 May 8;94(9):1339-41
pubmed: 16670705
Int J Epidemiol. 1994 Aug;23(4):691-9
pubmed: 8002181
J Clin Endocrinol Metab. 2005 Jul;90(7):3847-53
pubmed: 15827095
Int J Cancer. 2009 Jun 1;124(11):2737-43
pubmed: 19253366
Eur J Epidemiol. 2006;21(9):673-9
pubmed: 17048087